MaRS Discovery District is unusual among venture funds because it operates as a registered charity, real estate operator, and innovation hub whose commercial tenant revenue subsidizes discounted support for startups, all built on the site where insulin was first administered and founded by leaders who personally donated $14 million to commercialize Canadian research. Its investment side pairs a no-equity, one-on-one Capital Program aimed at top Canadian seed and Series A companies—meant to help them raise money without moving to the U.S.—with access to a curated cross-border investor network holding over $10 billion in assets, a long-running impact-investing fund called Catalyst Fund, and its own podcast that gives the startups it works with added visibility.